Abstract:Spherical crystallization is widely employed in pharmaceutical industry to produce spherical particles that exhibit improved micrometric performances of active pharmaceutical ingredients (APIs), including particle size, morphology, flowability, and compressibility. Especially for APIs with poor powder performance and low solubility, spherical co-crystallization offers the potential to enhance both dissolution properties and tablet manufacturability by combining the API and cocrystal coformer (CCF) into a spherical particle. In this study, we aimed to enhance the physicochemical properties of carbamazepine (CBZ) and hesperetin (HPE) by synthesizing a novel cocrystal with the stoichiometric ratio of 1:1. Crystal structure of the CBZ-HPE cocrystal was determined using single crystal X-ray diffraction (SCXRD). To further improve the poor powder performances such as low flowability and compressibility resulting from the needle morphology of the cocrystals, we designed three spherical crystallization strategies: common spherical agglomeration, oil-out-induced spherical agglomeration and spherulitic growth method. The spherical particles of CBZ-HPE cocrystals were characterized by powder X-ray diffraction (PXRD), polarized light microscopy (PLM), differential scanning calorimetry (DSC), scanning electron microscopy (SEM), thermogravimetric analysis (TGA), particle size instrumentation, and Fourier transform infrared spectroscopy (FTIR) to provide information about crystal structure, particle morphology, particle size and circularity distribution. The results revealed significant differences in particle morphology, flowability, particle size and dissolution rate among the various spherical crystallization strategies. Theoretical calculations elucidated three spherical crystallization mechanisms: spherical agglomeration (SA), oil-out-induced spherical agglomeration (OOSA) and spherulite growth (SG). This study offers both experimental and theoretical foundations for the application of different spherical crystallization techniques in the pharmaceutical industry.

Investigation into the Cooling Crystallization and Transformations of Carbamazepine Using in Situ Fbrm and Pvm

From Crystalline to Amorphous Structure of Carbamazepine Regulated by Dipeptide-Based Supramolecular Gel

Spray Drying as a Reliable Route to Produce Metastable Carbamazepine Form IV

In-situ analysis of self-assembled monolayer induced polymorphism in controlled crystallization of carbamazepine using quartz crystal microbalance technique

Recrystallization of commercial carbamazepine samples-a strategy to control dissolution variability

Formation Thermodynamics of Carbamazepine with Benzamide, Para-Hydroxybenzamide and Isonicotinamide Cocrystals: Experimental and Theoretical Study

Exploring Carbamazepine Polymorph Crystal Growth in Water by Enhanced Sampling Simulations

Sustainable preparation of spherical particles of novel carbamazepine-hesperetin cocrystal via different crystallization strategies: From mechanism to application

Thermodynamic Investigation of Carbamazepine-Saccharin Co-Crystal Polymorphs

Virtual Screening, Structural Analysis, and Formation Thermodynamics of Carbamazepine Cocrystals

Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder

Fabrication of Micro Spherulitic Particles of Carbamazepine-Hesperetin Cocrystal Via QESD with Enhanced Manufacturability and Dissolution

Cocrystals of carbamazepine: Structure, mechanical properties, fluorescence properties, solubility and dissolution rate

Molecular Dynamic Investigation on the Dissolution Behaviour of Carbamazepine Form III in Ethanol Solution

Comparison of the Four Anhydrous Polymorphs of Carbamazepine and the Crystal Structure of Form I.

Evaluation of focused beam reflectance measurement (FBRM) for monitoring and predicting the crystal size of carbamazepine in crystallization processes

Performance evaluation and application of molecularly imprinted polymer for separation of carbamazepine in aqueous solution

A Combined Molecular Dynamics and Experimental Study of Two-Step Process Enabling Low-Temperature Formation of Phase-Pure Α-Fapbi3.

Influence of Carbamazepine Dihydrate on the Preparation of Amorphous Solid Dispersions by Hot Melt Extrusion

Improving the Chemical Stability of Amorphous Solid Dispersion with Cocrystal Technique by Hot Melt Extrusion

Crystallization and intermolecular hydrogen bonding in carbamazepine-polyvinyl pyrrolidone solid dispersions: An experiment and molecular simulation study on drug content variation